307 related articles for article (PubMed ID: 3314551)
21. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia.
Apelseth TO; Hervig T; Bruserud O
Blood Rev; 2011 May; 25(3):113-22. PubMed ID: 21316823
[TBL] [Abstract][Full Text] [Related]
22. Management of patients refractory to platelet transfusion.
Chockalingam P; Sacher RA
J Infus Nurs; 2007; 30(4):220-5. PubMed ID: 17667077
[TBL] [Abstract][Full Text] [Related]
23. Strategies for managing refractoriness to platelet transfusions.
Dan ME; Schiffer CA
Curr Hematol Rep; 2003 Mar; 2(2):158-64. PubMed ID: 12901147
[TBL] [Abstract][Full Text] [Related]
24. The current status of platelet and granulocyte transfusions.
Seidl S; Kilp M
Haematologia (Budap); 1980; 13(1-4):145-54. PubMed ID: 7019021
[TBL] [Abstract][Full Text] [Related]
25. Optimizing platelet transfusion therapy.
Heal JM; Blumberg N
Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
[TBL] [Abstract][Full Text] [Related]
26. Platelet function testing to assess effectiveness of platelet transfusion therapy.
Salama ME; Raman S; Drew MJ; Abdel-Raheem M; Mahmood MN
Transfus Apher Sci; 2004 Apr; 30(2):93-100. PubMed ID: 15062745
[TBL] [Abstract][Full Text] [Related]
27. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
[TBL] [Abstract][Full Text] [Related]
28. Clinical evaluation of platelet transfusions in thrombocytopenic patients: methods and interpretation.
Kahn RA
Vox Sang; 1981; 40 Suppl 1():87-97. PubMed ID: 7293125
[No Abstract] [Full Text] [Related]
29. Diagnosis and management of refractoriness to platelet transfusion.
Schiffer CA
Blood Rev; 2001 Dec; 15(4):175-80. PubMed ID: 11792118
[TBL] [Abstract][Full Text] [Related]
30. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
Slichter SJ
J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
[TBL] [Abstract][Full Text] [Related]
31. Refractoriness to platelet transfusion following partial hepatectomy for hepatocellular carcinoma: report of two cases.
Kaibori M; Nagahama T; Yokoigawa N; Yanagida H; Nakamoto H; Kitade H; Satoi S; Onishi S; Kwon AH; Kamiyama Y
Hepatogastroenterology; 2003; 50(51):832-6. PubMed ID: 12828097
[TBL] [Abstract][Full Text] [Related]
32. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
[TBL] [Abstract][Full Text] [Related]
33. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
Menitove JE; Duquesnoy RJ
Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758
[TBL] [Abstract][Full Text] [Related]
34. Refractoriness to random donor platelet transfusions in patients with aplastic anaemia: a multivariate analysis of data from 264 cases.
Klingemann HG; Self S; Banaji M; Deeg HJ; Doney K; Slichter SJ; Thomas ED; Storb R
Br J Haematol; 1987 May; 66(1):115-21. PubMed ID: 3593647
[TBL] [Abstract][Full Text] [Related]
35. Pooled platelet concentrates provide a small benefit over single-donor platelets for patients with platelet refractoriness of any etiology.
Chu YH; Rose WN; Nawrot W; Raife TJ
J Int Med Res; 2021 May; 49(5):3000605211016748. PubMed ID: 34013757
[TBL] [Abstract][Full Text] [Related]
36. Guidelines for platelet transfusions. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force.
Murphy MF; Brozovic B; Murphy W; Ouwehand W; Waters AH
Transfus Med; 1992 Dec; 2(4):311-8. PubMed ID: 1339584
[TBL] [Abstract][Full Text] [Related]
37. The rational use of platelet transfusions in children.
Cahill MR; Lilleyman JS
Semin Thromb Hemost; 1998; 24(6):567-75. PubMed ID: 10066152
[TBL] [Abstract][Full Text] [Related]
38. Consensus and controversies in platelet transfusion.
Marwaha N; Sharma RR
Transfus Apher Sci; 2009 Oct; 41(2):127-33. PubMed ID: 19717344
[TBL] [Abstract][Full Text] [Related]
39. A contribution to the indications for platelet transfusion and determination of its therapeutic efficacy.
Kretschmer V; Huss B; Weber S; Bewarder S; Schulzki T; Köppler H; Heimanns J
Transfus Sci; 1994 Dec; 15(4):361-9. PubMed ID: 10155555
[TBL] [Abstract][Full Text] [Related]
40. POLYMORPHISM OF COLLECTION, TRANSFUSION AND EFFECTIVENESS OF DONOR PLATELETS CONCENTRATES.
Gubanova MN; Ayupova RF; Zhiburt EB
Anesteziol Reanimatol; 2017 Jan; 62(1):77-79. PubMed ID: 29932588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
